A drug currently being used to treat ischemic strokes may prove to be a significant advance in the treatment of tuberculosis and ulcers. In a new research report appearing online in The FASEB Journal, a compound called ebselen effectively inhibits the thioredoxin reductase system in a wide variety of bacteria, including Helicobacter pylori which causes gastric ulcers and Mycobacterium tuberculosis which causes tuberculosis. Thioredoxin and thioredoxin reductase proteins are essential for bacteria to make new DNA, and protect them against oxidative stress caused by the immune system. Targeting this system with ebselen, and others compounds like it, represents a new approach toward eradicating these bacteria.
"This new antibacterial principle provides better chances of surviving an infection," said Arne Holmgren, M.D., Ph.D., a researcher involved in the work from the Division of Biochemistry in the Department of Medical Biochemistry and Biophysics, at Karolinska Institutet in Stockholm, Sweden. "Since ebselen is also an antioxidant, the present mechanism can be described as a 'two for the price of one' antioxidant action in inflammation, and specific targeting of multi-resistant bacterial complications and sepsis."
Building on previous observations where ebselen has shown antibacterial properties against some bacteria, Holmgren and colleagues hypothesized that the bacteria sensitive to ebselen relied solely on thioredoxin and thioredoxin reductase for essential cellular processes. They investigated this by testing it on strains of E. coli with deletions in the genes for thioredoxin, thioredoxin reductase and the glutaredoxin system. They found that strains with deletions in the genes coding for glutaredoxin system were much more sensitive than normal bacteria. Researchers further tested ebselen against Helicobacter pylori and Mycobacterium tuberculosis, which both naturally lack the glutaredoxin system and are frequently resistant to many commonly used antibiotics, and found both to be sensitive to ebselen.
"As rapidly as these organisms evolve, we need new drugs sooner rather than later," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "The fact that these scientists have found a new target for killing some of the most resistant bacteria is great news, but the fact that we already have at least one drug which we could possibly use now makes the news even better."
Federation of American Societies for Experimental Biology: http://www.faseb.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Some, like dolphins or chimps, are sophisticated communicators. But do they have their own languages? Its a question that misses the point
Grey and harbour seals in the North Sea weave in and out of offshore wind farms in search of fish, which gather around turbines
Researchers have created wheat that is resistant to a common disease, using advanced gene editing methods.
An archaeological dig uncovers new clues about life and death in America's early history
Ted Stanley is giving $650 million to the Broad Institute of MIT and Harvard to find and treat the genetic underpinnings of mental illnesses. His son has bipolar disorder.
As far as agricultural genome research goes, this may be the best thing since sliced bread - wheat bread, that is.
The discovery and culturing of bacteria that eat and excrete electrons means we may soon find out just how little electricity fundamental life requires
The spectacularly well-preserved prehistoric sea creature sported compound eyes, body armor and two spiky claws for grabbing prey
The Beagle's library of more than 400 books has been reconstructed and made freely available in digital form
When the gorilla Willie B. had to move to a tiny cage at the Atlanta Zoo for six months, the vet staff decided to put Thorazine in the Coca-Cola he drank in the morning. Willie responded to the drug as many institutionalized humans do: He shuffled back and forth across his cage with dulled eyes.